Estados Unidos · Revistas de economía · CNN Business

FDA scientists opposed the Trump administration’s move to ease peptides access

Publicado por CNN Business · Estados Unidos hace 15 h

A plan to give people in the United States easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug…

Leer el artículo completo en CNN Business Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnn.com)

FDA scientists opposed the Trump administration’s move to ease peptides access

También te puede interesar

Delta Just Replaced the Best Way to Get Customer Service With an AI Chatbot

How 8 protests fed into U.S. legal change, from statutes to court rulings

3 Timing Problems With Your Feedback Structure — and How to Fix Them

Alphabet’s Google Cloud revenue doubles to $31 billion as cash flow stays deep red

Could These 4 Money Mistakes Be Haunting You?

Wall Street forecasters are eyeing a streak of double-digit gains brewing for stocks

FDA scientists opposed the Trump administration’s move to ease peptides access

Compartir

También te puede interesar

Delta Just Replaced the Best Way to Get Customer Service With an AI Chatbot

How 8 protests fed into U.S. legal change, from statutes to court rulings

3 Timing Problems With Your Feedback Structure — and How to Fix Them

Alphabet’s Google Cloud revenue doubles to $31 billion as cash flow stays deep red

Could These 4 Money Mistakes Be Haunting You?

Wall Street forecasters are eyeing a streak of double-digit gains brewing for stocks